2018
Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson’s disease
Authors:
Blauwendraat, C., Kia, D.A., Pihlstrom. L,, Gan-Or, Z., Lesage, S., Gibbs, J.R., Ding, J., Alcalay, R.N., Hassin-Baer, S., Pittman, A.M., Brooks, J., Edsall, C., Chung, S.J., Goldwurm, S., Toft, M., Schulte, C., International Parkinson's Disease Genomics C, COURAGE-PD C, Hernandez, D., Singleton, A.B., Nalls, M.A., Brice, A., Scholz, S.W., & Wood, N.W.
Journal:
Neurobiology of Aging
Share
Receive the
latest news
Stay updated with the latest research developments from CCNA-CCNV. Our news section provides insights into cutting-edge studies, advancements in dementia care, and key findings in brain health research.
